Загрузка...
State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2
INTRODUCTION: The extreme health and economic problems in the world due to the SARS-CoV-2 infection have led to an urgent need to identify potential drug targets for treating coronavirus disease 2019 (COVID-19). The present state-of-the-art tool-based screening was targeted to identify drug targets...
Сохранить в:
| Опубликовано в: : | Arch Med Sci |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Termedia Publishing House
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7212215/ https://ncbi.nlm.nih.gov/pubmed/32399096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2020.94567 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|